{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Clomiphene citrate", "Endometrial receptivity", "Phosal-based formulation", "Sustained release"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32483681", "DateCompleted": {"Year": "2021", "Month": "08", "Day": "27"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "06", "Day": "02"}], "Language": ["eng"], "ELocationID": ["10.1007/s40199-019-00310-2"], "Journal": {"ISSN": "2008-2231", "JournalIssue": {"Volume": "28", "Issue": "2", "PubDate": {"Year": "2020", "Month": "Dec"}}, "Title": "Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences", "ISOAbbreviation": "Daru"}, "ArticleTitle": "Design and evaluation of a novel nanodrug delivery system for reducing the side effects of clomiphene citrate on endometrium.", "Pagination": {"StartPage": "423", "EndPage": "432", "MedlinePgn": "423-432"}, "Abstract": {"AbstractText": ["Stimulation of ovulation with clomiphene citrate can cause side effects on endometrial receptivity. Formulation with nano-size may be an alternative therapy for women with ovulatory disorders. In this study, we investigated sustained-release clomiphene citrate by using Phosal-based formulation (PBF) and evaluate its decreased side effect on the endometrial receptivity.", "In the in-vitro study, CC loaded PBF was analyzed using Zetasizer, Fourier-transform infrared spectroscopy (FTIR), and Transmission electron microscopy (TEM). In the in-vivo study, 24 female mice were randomly divided into three groups: CC (5\u00a0mg/kg), CC/PBF (5\u00a0mg/kg) and SS (1\u00a0ml) daily administered and injected with 5\u00a0IU HCG and mated after two days. At day 4.5, pregnant mice were euthanized and endometrial tissue was extracted for quantitative polymerase chain reaction (Q-PCR) analysis.", "The optimized PBF contained Phosal 50PG/glycerol in a 2:8 ratios (w/w) and the particle size of optimum formulation was 67\u2009\u00b1\u20090.30551\u00a0nm and the release of CC from CC-containing PBF was slightly faster in the first 24\u00a0h; wherein, 29% of CC was released, and 76% of CC was released up to 120\u00a0h. The mRNA levels of leukemia inhibitory factor (LIF), leukemia inhibitory factor receptor alpha (LIFR), HOXA10, Heparin-binding epidermal growth factor (HB-EGF), and epidermal growth factor (EGF) were significantly upregulated and MUC1 and PGR mRNA levels were significantly downregulated in the CC-containing PBF-treated animals compared with only CC group (P\u00a0<\u20090.05).", "Sustained release formulation of clomiphene citrate increased its targeting efficiency and improved the impact of the CC on implantation. Graphical abstract A new Phosal Based Formulation (PBF) was designed to decrease the side effects of Clomiphene citrate (CC) on endometrium. This drug formulation could react better during implantation by increasing the expression of genes involved in implantation. The in vivo study demonstrated that the CC-containing PBF in mice has a significantly higher endometrial receptivity, compared with the suspension."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Ajdary", "ForeName": "Marziyeh", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Keyhanfar", "ForeName": "Fariborz", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran."}], "LastName": "Aflatoonian", "ForeName": "Reza", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}, {"Identifier": [], "Affiliation": "Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Amani", "ForeName": "Amir", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomical Science, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Amjadi", "ForeName": "FatemehSadat", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomical Science, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Zandieh", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran. mehdizadeh.m@iums.ac.ir."}, {"Identifier": [], "Affiliation": "Department of Anatomical Science, Iran University of Medical Sciences, Tehran, Iran. mehdizadeh.m@iums.ac.ir."}], "LastName": "Mehdizadeh", "ForeName": "Mehdi", "Initials": "M"}], "GrantList": [{"GrantID": "94-05-117-27524", "Agency": "Iran University of Science and Technology", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Daru", "NlmUniqueID": "101125969", "ISSNLinking": "1560-8115"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Delayed-Action Preparations"}, {"RegistryNumber": "0", "NameOfSubstance": "Fertility Agents, Female"}, {"RegistryNumber": "0", "NameOfSubstance": "Genetic Markers"}, {"RegistryNumber": "1HRS458QU2", "NameOfSubstance": "Clomiphene"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["adverse effects", "chemistry"], "DescriptorName": "Clomiphene"}, {"QualifierName": [], "DescriptorName": "Delayed-Action Preparations"}, {"QualifierName": [], "DescriptorName": "Drug Compounding"}, {"QualifierName": [], "DescriptorName": "Drug Delivery Systems"}, {"QualifierName": ["chemistry", "drug effects"], "DescriptorName": "Endometrium"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Fertility Agents, Female"}, {"QualifierName": [], "DescriptorName": "Gene Expression Profiling"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Genetic Markers"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Models, Animal"}, {"QualifierName": [], "DescriptorName": "Nanoparticles"}, {"QualifierName": [], "DescriptorName": "Particle Size"}, {"QualifierName": [], "DescriptorName": "Pregnancy"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Lai M, Ma H, Song X. Electroacupuncture combined with clomiphene promotes pregnancy and blastocyst implantation possibly by up-regulating expression of insulin receptor and insulin receptor substrate 1 proteins in endometrium in rats with PCOS. Zhen Ci Yan Jiu. 2016;41(5):435\u2013439.", "ArticleIdList": ["29071945"]}, {"Citation": "Bao SH, Le Sheng S, Peng YF, De Lin Q. Effects of letrozole and clomiphene citrate on the expression of HOXA10 and integrin \u03b1v\u03b23 in uterine epithelium of rats. Fertil Steril. 2009;91(1):244\u2013248. doi: 10.1016/j.fertnstert.2007.11.024.", "ArticleIdList": ["10.1016/j.fertnstert.2007.11.024", "18249394"]}, {"Citation": "Omran E, El-Sharkawy M, El-Mazny A, Hammam M, Ramadan W, Latif D, et al. Effect of clomiphene citrate on uterine hemodynamics in women with unexplained infertility. Int J Women's Health. 2018;10:147\u2013152. doi: 10.2147/IJWH.S155335.", "ArticleIdList": ["10.2147/IJWH.S155335", "PMC5894743", "29670406"]}, {"Citation": "Mehdinejadiani S, Amidi F, Mehdizadeh M, Barati M, Pazhohan A, Alyasin A, et al. Effects of letrozole and clomiphene citrate on Wnt signaling pathway in endometrium of polycystic ovarian syndrome and healthy women. Biol Reprod. 2018;100(3):641\u2013648. doi: 10.1093/biolre/ioy187.", "ArticleIdList": ["10.1093/biolre/ioy187", "30184105"]}, {"Citation": "van Hoogevest P. Review\u2013an update on the use of oral phospholipid excipients. Eur J Pharm Sci. 2017;108:1\u201312. doi: 10.1016/j.ejps.2017.07.008.", "ArticleIdList": ["10.1016/j.ejps.2017.07.008", "28711714"]}, {"Citation": "Fricker G, Kromp T, Wendel A, Blume A, Zirkel J, Rebmann H, et al. Phospholipids and lipid-based formulations in oral drug delivery. Pharm Res. 2010;27(8):1469\u20131486. doi: 10.1007/s11095-010-0130-x.", "ArticleIdList": ["10.1007/s11095-010-0130-x", "20411409"]}, {"Citation": "Carlson R, Hartman D, Ochalski S, Zimmerman J, Glaser K. Sirolimus (rapamycin, Rapamune\u00ae) and combination therapy with cyclosporin a in the rat developing adjuvant arthritis model: correlation with blood levels and the effects of different oral formulations. Inflamm Res. 1998;47(8):339\u2013344. doi: 10.1007/s000110050339.", "ArticleIdList": ["10.1007/s000110050339", "9754868"]}, {"Citation": "Hauss DJ. Oral lipid-based formulations. Adv Drug Deliv Rev. 2007;59(7):667\u2013676. doi: 10.1016/j.addr.2007.05.006.", "ArticleIdList": ["10.1016/j.addr.2007.05.006", "17618704"]}, {"Citation": "Khani S, Abbasi S, Keyhanfar F, Amani A. Use of artificial neural networks for analysis of the factors affecting particle size in mebudipine nanoemulsion. J Biomol Struct Dyn. 2019;37(12):3162\u20133167. doi: 10.1080/07391102.2018.1510341.", "ArticleIdList": ["10.1080/07391102.2018.1510341", "30238824"]}, {"Citation": "Khani S, Keyhanfar F. Improved oral bioavalability of mebudipine upon administration in PhytoSolve and Phosal-based formulation (PBF) AAPS PharmSciTech. 2014;15(1):96\u2013102. doi: 10.1208/s12249-013-0039-x.", "ArticleIdList": ["10.1208/s12249-013-0039-x", "PMC3909151", "24151144"]}, {"Citation": "Bali V, Ali M, Ali J. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf B Biointerfaces. 2010;76(2):410\u2013420. doi: 10.1016/j.colsurfb.2009.11.021.", "ArticleIdList": ["10.1016/j.colsurfb.2009.11.021", "20042320"]}, {"Citation": "AL-Rekabi SA. Histological and hormonal study on effect of clomiphene citrate (CC) on some reproductive and embryonic parameters in female mice. IJEIR. 2017;7(1):7\u201316. doi: 10.28969/IJEIR/2.", "ArticleIdList": ["10.28969/IJEIR/2"]}, {"Citation": "Nelson LM, Hershlag A, Kurl RS, Hall JL, Stillman RJ. Clomiphene citrate directly impairs endometrial receptivity in the mouse. Fertil Steril. 1990;53(4):727\u2013731. doi: 10.1016/S0015-0282(16)53472-4.", "ArticleIdList": ["10.1016/S0015-0282(16)53472-4", "2318331"]}, {"Citation": "London SN, Young D, Caldito G, Mailhes JB. Clomiphene citrate-induced perturbations during meiotic maturation and cytogenetic abnormalities in mouse oocytes in vivo and in vitro. Fertil Steril. 2000;73(3):620\u2013626. doi: 10.1016/S0015-0282(99)00549-X.", "ArticleIdList": ["10.1016/S0015-0282(99)00549-X", "10689023"]}, {"Citation": "Smeriglio VL, Wilcox HC. Prenatal drug exposure and child outcome. Clin Perinatol. 1999;26(1):1\u201316. doi: 10.1016/S0095-5108(18)30069-1.", "ArticleIdList": ["10.1016/S0095-5108(18)30069-1", "10214540"]}, {"Citation": "Amjadi F, Aflatoonian R, Javanmard SH, Saifi B, Ashrafi M, Mehdizadeh M. Apolipoprotein A1 as a novel anti-implantation biomarker in polycystic ovary syndrome: a case-control study. J Res Med Sci. 2015;20(11):1039\u20131045. doi: 10.4103/1735-1995.172813.", "ArticleIdList": ["10.4103/1735-1995.172813", "PMC4755089", "26941806"]}, {"Citation": "Salam EA, Essam ME, ElSawy NA. Effect of clomiphene citrate on the ovary of adult rat. JOKULL. 2015;65(12):26\u201344."}, {"Citation": "Barnes LE, Meyer RK. Effects of ethamoxytriphetol, MRL-37, and clomiphene on reproduction in rats. Fertil Steril. 1962;13(5):472\u2013480. doi: 10.1016/S0015-0282(16)34632-5.", "ArticleIdList": ["10.1016/S0015-0282(16)34632-5", "13865101"]}, {"Citation": "Gadalla MA, Huang S, Wang R, Norman RJ, Abdullah SA, El Saman AM, et al. Effect of clomiphene citrate on endometrial thickness, ovulation, pregnancy and live birth in anovulatory women: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(1):64\u201376. doi: 10.1002/uog.18933.", "ArticleIdList": ["10.1002/uog.18933", "29055102"]}, {"Citation": "Chen C, Yan Q, Liu K, Zhou X, Xian Y, Liang D, et al. Endometrial receptivity markers in mice stimulated with raloxifene versus clomiphene citrate and natural cycles. Reprod Sci. 2016;23(6):748\u2013755. doi: 10.1177/1933719115616496.", "ArticleIdList": ["10.1177/1933719115616496", "26603317"]}, {"Citation": "Montasser I, Fessi H, Coleman A. Atomic force microscopy imaging of novel type of polymeric colloidal nanostructures. Eur J Pharm Biopharm. 2002;54(3):281\u2013284. doi: 10.1016/S0939-6411(02)00087-5.", "ArticleIdList": ["10.1016/S0939-6411(02)00087-5", "12445557"]}, {"Citation": "Patel MH, Mundada VP, Sawant KK. Novel drug delivery approach via self-microemulsifying drug delivery system for enhancing Oral bioavailability of Asenapine maleate: optimization, characterization, cell uptake, and in vivo pharmacokinetic studies. AAPS PharmSciTech. 2019;20(2):44. doi: 10.1208/s12249-018-1212-z.", "ArticleIdList": ["10.1208/s12249-018-1212-z", "30617712"]}, {"Citation": "Bocca S, Real EB, Lynch S, Stadtmauer L, Beydoun H, Mayer J, et al. Impact of serum estradiol levels on the implantation rate of cleavage stage cryopreserved-thawed embryos transferred in programmed cycles with exogenous hormonal replacement. J Assist Reprod Genet. 2015;32(3):395\u2013400. doi: 10.1007/s10815-014-0402-1.", "ArticleIdList": ["10.1007/s10815-014-0402-1", "PMC4363240", "25563580"]}, {"Citation": "Ertzeid G, Storeng R. The impact of ovarian stimulation on implantation and fetal development in mice. Hum Reprod. 2001;16(2):221\u2013225. doi: 10.1093/humrep/16.2.221.", "ArticleIdList": ["10.1093/humrep/16.2.221", "11157810"]}, {"Citation": "Lee B, Du H, Taylor HS. Experimental murine endometriosis induces DNA methylation and altered gene expression in eutopic endometrium. Biol Reprod. 2009;80(1):79\u201385. doi: 10.1095/biolreprod.108.070391.", "ArticleIdList": ["10.1095/biolreprod.108.070391", "PMC2804809", "18799756"]}, {"Citation": "Aplin JD, Meseguer M, Simon C, Ortiz ME, Croxatto H, Jones CJ. MUC1, glycans and the cell-surface barrier to embryo implantation. Biochem Soc Trans. 2001;29(Pt 2):153\u2013156. doi: 10.1042/0300-5127:0290153.", "ArticleIdList": ["10.1042/0300-5127:0290153", "11356144"]}, {"Citation": "Dixon D, He H, Haseman JK. Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium. Environ Health Perspect. 2000;108(Suppl 5):795\u2013802. doi: 10.1289/ehp.00108s5795.", "ArticleIdList": ["10.1289/ehp.00108s5795", "11035985"]}, {"Citation": "Chen CR, Yan QX, Zhou XQ, Xian YJ, Guo XY, Quan S. Effects of raloxifene at two different doses for ovulation induction on endometrial pinopodes in mice during the implantation window. Nan Fang Yi Ke Da Xue Xue Bao. 2018;38(2):234\u2013238.", "ArticleIdList": ["PMC6743885", "29502066"]}, {"Citation": "Mueller MD, Vigne JL, Minchenko A, Lebovic DI, Leitman DC, Taylor RN. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc Natl Acad Sci U S A. 2000;97(20):10972\u201310977. doi: 10.1073/pnas.200377097.", "ArticleIdList": ["10.1073/pnas.200377097", "PMC27133", "10995484"]}, {"Citation": "Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol. 1998;141(7):1659\u20131673. doi: 10.1083/jcb.141.7.1659.", "ArticleIdList": ["10.1083/jcb.141.7.1659", "PMC2132998", "9647657"]}, {"Citation": "Moller B, Rasmussen C, Lindblom B, Olovsson M. Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle. Mol Hum Reprod. 2001;7(1):65\u201372. doi: 10.1093/molehr/7.1.65.", "ArticleIdList": ["10.1093/molehr/7.1.65", "11134362"]}, {"Citation": "Wang H, Shi G, Li M, Fan H, Ma H, Sheng L. Correlation of IL-1 and HB-EGF with endometrial receptivity. Exp Ther Med. 2018;16(6):5130\u20135136. doi: 10.3892/etm.2018.6840.", "ArticleIdList": ["10.3892/etm.2018.6840", "PMC6257333", "30542468"]}, {"Citation": "Kumar P, Mahajan S. Preimplantation and postimplantation therapy for the treatment of reproductive failure. J Hum Reprod Sci. 2013;6(2):88\u201392. doi: 10.4103/0974-1208.117165.", "ArticleIdList": ["10.4103/0974-1208.117165", "PMC3778611", "24082648"]}, {"Citation": "Lanza FL, Marathi UK, Anand BS, Lichtenberger LM. Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients. Aliment Pharmacol Ther. 2008;28(4):431\u2013442. doi: 10.1111/j.1365-2036.2008.03765.x.", "ArticleIdList": ["10.1111/j.1365-2036.2008.03765.x", "PMC3353548", "18549459"]}, {"Citation": "Semalty A, Semalty M, Singh D, Rawat MS. Development and physicochemical evaluation of pharmacosomes of diclofenac. Acta Pharma. 2009;59(3):335\u2013344. doi: 10.2478/v10007-009-0023-x.", "ArticleIdList": ["10.2478/v10007-009-0023-x", "19819829"]}, {"Citation": "Foroughi S, Ziamajidi N, Javid S, Abbasalipourkabir R, Aflatoonian R, Ashrafi M, Nourian A. Study of telomerase reverse transcriptase and uterine-ovarian-specific genes expression in the endometrial tissue of ovariectomized female Sprague-Dawley rats. Int J Biol Macromol. 2018;113:1302\u20131307. doi: 10.1016/j.ijbiomac.2018.02.115.", "ArticleIdList": ["10.1016/j.ijbiomac.2018.02.115", "29471091"]}, {"Citation": "Saesoo S, Bunthot S, Sajomsang W, Gonil P, Phunpee S, Songkhum P, Laohhasurayotin K, Wutikhun T, Yata T, Ruktanonchai UR, Saengkrit N. Phospholipid-chitosan hybrid nanoliposomes promoting cell entry for drug delivery against cervical cancer. J Colloid Interface Sci. 2016;480:240\u2013248. doi: 10.1016/j.jcis.2016.06.071.", "ArticleIdList": ["10.1016/j.jcis.2016.06.071", "27442151"]}, {"Citation": "Ma Y, Zhao X, Li J, Shen Q. The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability. Int J Nanomedicine. 2012;7:559\u2013570. doi: 10.2147/ijn.s27641.", "ArticleIdList": ["10.2147/ijn.s27641", "PMC3277436", "22346351"]}, {"Citation": "Sriraman SK, Salzano G, Sarisozen C, Torchilin V. Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid. Eur J Pharm Biopharm. 2016;105:40\u201349. doi: 10.1016/j.ejpb.2016.05.023.", "ArticleIdList": ["10.1016/j.ejpb.2016.05.023", "PMC4931959", "27264717"]}, {"Citation": "Julius JM, Tanyi JL, Nogueras-Gonzalez GM, Watkins JL, Coleman RL, Wolf JK, Smith JA. Evaluation of pegylated liposomal doxorubicin dose on the adverse drug event profile and outcomes in treatment of recurrent endometrial cancer. Int J Gynecol Cancer. 2013;23(2):348\u2013354. doi: 10.1097/IGC.0b013e31827c18f3.", "ArticleIdList": ["10.1097/IGC.0b013e31827c18f3", "PMC3899886", "23295941"]}]}], "History": [{"Year": "2019", "Month": "3", "Day": "20"}, {"Year": "2019", "Month": "10", "Day": "23"}, {"Year": "2020", "Month": "6", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "2"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32483681", "PMC7704853", "10.1007/s40199-019-00310-2", "10.1007/s40199-019-00310-2"]}}]}